.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Colorcon
McKinsey
Deloitte
Teva
US Department of Justice
Cerilliant
Chubb
Citi

Generated: November 24, 2017

DrugPatentWatch Database Preview

PROVIGIL Drug Profile

« Back to Dashboard

Which patents cover Provigil, and what generic Provigil alternatives are available?

Provigil is a drug marketed by Cephalon and is included in one NDA. There is one patent protecting this drug.

The generic ingredient in PROVIGIL is modafinil. There are twenty-six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the modafinil profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-001Dec 24, 1998ABRXYesNo► Subscribe► SubscribeY► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-002Dec 24, 1998ABRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PROVIGIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-001Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-001Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-002Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-002Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-002Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-002Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-001Dec 24, 1998► Subscribe► Subscribe
Cephalon
PROVIGIL
modafinil
TABLET;ORAL020717-001Dec 24, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Colorcon
AstraZeneca
Novartis
McKesson
Merck
Harvard Business School
Citi
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot